HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
174373.0,234940,2181-10-15 07:38:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses with NS for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine (need to verify speciation and sensitivities of GNR)
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, might
   consider pulling lines, but also concern for enterococcus; will await
   to see if coag negative or positive
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   -not candidate for MRCP b/c has pacer. Does not seem stable enough for
   ERCP and likely not any obstruction/intervention
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
   -somewhat [**Last Name (LF) 8601**], [**First Name3 (LF) **] try to come down on midazolam and see response
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.2.5 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   - d/c remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs; correct coagulopathy if bleeding
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: None (too much bruising with boots)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses with NS for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine (need to verify speciation and sensitivities of GNR)
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, might
   consider pulling lines, but also concern for enterococcus; will await
   to see if coag negative or positive
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   -not candidate for MRCP b/c has pacer. Does not seem stable enough for
   ERCP and likely not any obstruction/intervention
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
   -somewhat [**Last Name (LF) 8601**], [**First Name3 (LF) **] try to come down on midazolam and see response
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.2.5 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   - d/c remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs; correct coagulopathy if bleeding
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: None (too much bruising with boots)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided physician's daily progress note, I summarize the patient's health progress in the ICU as follows:

**Chief Complaint:** The patient is a 81-year-old female presenting with progressive painless jaundice over the past two weeks, now presenting with hypotension and hypothermia, likely representing sepsis.

**24-Hour Events:**

* Ultrasound of the right upper quadrant (RUQ) showed fatty liver and no ductal abnormalities.
* Urine culture is pending, but the preliminary result shows Gram-negative rods (GNR) in excess of 100,000 organisms/mL.
* Blood culture is pending, but the preliminary result shows Gram-positive cocci (GPC) in clusters.
* The patient is receiving broad-spectrum antibiotics, including meropenem, flagyl, and vancomycin.
* The patient is on two pressors, phenylephrine, and vasopressin, with a goal mean arterial pressure (MAP) above 65.
* The patient's lactate level is trending down from 5.8 to 3.4, likely due to infection rather than hypotension.

**Assessment and Plan:**

* The patient has septic shock, likely due to urosepsis, cholangitis, or a line infection.
* The patient has metabolic acidosis, likely due to lactic acidosis, and is receiving empiric antibiotics.
* The patient has elevated liver function tests (LFTs) and cholestasis, likely due to intrhepatic biliary obstruction or intrahepatic etiology.
* The patient has acute renal failure, likely hemodynamic in origin, and is receiving renally dosed medications.
* The patient has bilateral pleural effusions, likely contributing to hypoxia, and is being monitored for further progression.
* The patient has atrial fibrillation with rapid ventricular rate (RVR) and is being held off from nodal blocker due to the tenous nature of blood pressure.
* The patient has diastolic heart failure and is being held off from beta-blocker and lasix due to hemodynamic instability.

**Potential Medical Complications:**

* Sepsis and septic shock may lead to organ dysfunction, including acute kidney injury, liver failure, and respiratory failure.
* Metabolic acidosis may worsen if not managed promptly.
* Cholestasis may lead to liver failure if not addressed.
* Acute renal failure may progress to chronic kidney disease if not managed promptly.
* Bilateral pleural effusions may worsen hypoxia if not managed promptly.
* Atrial fibrillation with RVR may lead to cardiac arrhythmias and worsen blood pressure instability.
* Diastolic heart failure may worsen if not managed promptly.

**Recommendations:**

* Continue broad-spectrum antibiotics and adjust dosing as necessary.
* Monitor lactate levels and adjust empiric antibiotics as necessary.
* Consider repeat RUQ ultrasound to rule out ductal obstruction.
* Monitor coagulopathy and correct if necessary.
* Continue to trend ABG and lactate levels.
* Consider thoracentesis if hypoxia worsens.
* Hold off on nodal blocker and coumadin due to the tenous nature of blood pressure.
* Continue to monitor for signs of worsening sepsis, metabolic acidosis, and cholestasis."
174373.0,234940,2181-10-15 07:38:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, would
   consider pulling lines...
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in these
   septic patient. Lactate trending down now with broad spectrum
   antibiotics and adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.3 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   zosyn, levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   -consider d/c'ing remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control: Blood sugar well controlled
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication: ICU consent signed
   HCP: Daughter: [**Name (NI) 9831**]: (H)[**Telephone/Fax (1) 10126**], (C)[**Telephone/Fax (1) 10127**] and son [**Name (NI) **]
   [**Name (NI) 36**] status: Full code
   Disposition: ICU
   ------ Protected Section ------
   MICU ATTENDING ADDENDUM
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   note above, including the assessment and plan. I would emphasize and
   add the following points: 81F AF, dCHF, prior chole, recent ESBL klebs
   UTI p/w initial problem of obstructive LFTs / intrahepatic cholestasis
   at [**Hospital3 **]. On arrival to [**Hospital 19**] medical floor, found to be
   hypotensive, hypothermic and hypoxemic with metabolic acidosis on
   arrival. Intuibated, lined, bronched on arrival to MICU, now on broad
   spectrum antibiotics and max neo / VPA. Seen by ERCP - procedure
   deferred.
   Exam notable for Tm 99.3 BP 96/60 HR 110 RR 20 with sat on 450x20 5 0.5
   27/22 7.22/21/149. 3+ edema TBB +8L/LOS CVP 16. Labs notable for WBC
   16K, HCT 28, K+ 4, Cr 1.2, lactate 5.3, AP 1090, TB 16.3, ALT 609, AST
   1215, LDH 1277. CXR with R effusion, LLL ASD.
   81F smoldering intrahepatic cholestatic picture now p/w likely
   refractory septic shock d/t urosepsis and/or biliary sepsis c/b MOSF.
   Agree with plan to manage shock with ongoing IVF resuscitation, follow
   CVO2, check echo, and continue IVF boluses for CVP >16-18 range. Will
   check repeat RUQ USG, ERCP following, while continuing vanco / [**Last Name (un) 614**] /
   flagyl / HC. Suspect met acidosis is combined effect of ARF and
   elevated lactate, though ischemic bowel is a concern as a primary or
   secondary mechanism
 I- abd CT when stable. LFT abnormalities
   suggestive of drug-induced intrahepatic disease, await anti-SM Ab and
   liver eval; other infiltrative processes including PBC / PSC / lymphoma
   / amyloidosis possible but less likely. Respiratory failure  - continue
   AC vent, f/u BAL, hold on tap of effusions, transition to ARDS vent
   with Vt 300cc. ARF likely hemodynamic - RD meds, check lytes. NPO for
   now, HSC, [**Last Name (LF) 1618**], [**First Name3 (LF) **] line, full. Will meet with family today. Remainder
   of plan as outlined above.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, would
   consider pulling lines...
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in these
   septic patient. Lactate trending down now with broad spectrum
   antibiotics and adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.3 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   zosyn, levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   -consider d/c'ing remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control: Blood sugar well controlled
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication: ICU consent signed
   HCP: Daughter: [**Name (NI) 9831**]: (H)[**Telephone/Fax (1) 10126**], (C)[**Telephone/Fax (1) 10127**] and son [**Name (NI) **]
   [**Name (NI) 36**] status: Full code
   Disposition: ICU
   ------ Protected Section ------
   MICU ATTENDING ADDENDUM
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   note above, including the assessment and plan. I would emphasize and
   add the following points: 81F AF, dCHF, prior chole, recent ESBL klebs
   UTI p/w initial problem of obstructive LFTs / intrahepatic cholestasis
   at [**Hospital3 **]. On arrival to [**Hospital 19**] medical floor, found to be
   hypotensive, hypothermic and hypoxemic with metabolic acidosis on
   arrival. Intuibated, lined, bronched on arrival to MICU, now on broad
   spectrum antibiotics and max neo / VPA. Seen by ERCP - procedure
   deferred.
   Exam notable for Tm 99.3 BP 96/60 HR 110 RR 20 with sat on 450x20 5 0.5
   27/22 7.22/21/149. 3+ edema TBB +8L/LOS CVP 16. Labs notable for WBC
   16K, HCT 28, K+ 4, Cr 1.2, lactate 5.3, AP 1090, TB 16.3, ALT 609, AST
   1215, LDH 1277. CXR with R effusion, LLL ASD.
   81F smoldering intrahepatic cholestatic picture now p/w likely
   refractory septic shock d/t urosepsis and/or biliary sepsis c/b MOSF.
   Agree with plan to manage shock with ongoing IVF resuscitation, follow
   CVO2, check echo, and continue IVF boluses for CVP >16-18 range. Will
   check repeat RUQ USG, ERCP following, while continuing vanco / [**Last Name (un) 614**] /
   flagyl / HC. Suspect met acidosis is combined effect of ARF and
   elevated lactate, though ischemic bowel is a concern as a primary or
   secondary mechanism
 I- abd CT when stable. LFT abnormalities
   suggestive of drug-induced intrahepatic disease, await anti-SM Ab and
   liver eval; other infiltrative processes including PBC / PSC / lymphoma
   / amyloidosis possible but less likely. Respiratory failure  - continue
   AC vent, f/u BAL, hold on tap of effusions, transition to ARDS vent
   with Vt 300cc. ARF likely hemodynamic - RD meds, check lytes. NPO for
   now, HSC, [**Last Name (LF) 1618**], [**First Name3 (LF) **] line, full. Will meet with family today. Remainder
   of plan as outlined above.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's medical history and current condition, the following potential medical complications can arise:

1. Sepsis: The patient is already experiencing septic shock, and the risk of further complications, such as organ dysfunction, acute respiratory distress syndrome (ARDS), and acute kidney injury (AKI), is high.
2. Acute Respiratory Distress Syndrome (ARDS): The patient's respiratory status is critical, and the risk of developing ARDS is high, especially given the presence of bilateral pleural effusions and the need for mechanical ventilation.
3. Acute Kidney Injury (AKI): The patient's kidney function is impaired, and the risk of developing AKI is high, especially given the presence of sepsis and the need for vasopressors.
4. Liver Failure: The patient's liver function is abnormal, and the risk of developing liver failure is high, especially given the presence of cholestasis and the need for further evaluation and treatment.
5. Coagulopathy: The patient's coagulation profile is abnormal, and the risk of bleeding is high, especially given the presence of sepsis and the need for vasopressors.
6. Infection: The patient has a high risk of developing further infections, especially given the presence of central lines and the need for antibiotics.
7. Cardiac Complications: The patient's cardiac status is critical, and the risk of developing cardiac complications, such as cardiogenic shock, is high, especially given the presence of atrial fibrillation and the need for vasopressors.
8. Gastrointestinal Complications: The patient's gastrointestinal status is critical, and the risk of developing gastrointestinal complications, such as gastrointestinal bleeding, is high, especially given the presence of sepsis and the need for vasopressors.
9. Neurological Complications: The patient's neurological status is critical, and the risk of developing neurological complications, such as cerebral edema, is high, especially given the presence of sepsis and the need for vasopressors.

To mitigate these risks, the patient should be closely monitored and receive aggressive treatment for their underlying conditions, including sepsis, ARDS, AKI, liver failure, and coagulopathy."
174373.0,234940,2181-10-16 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum and vancomycin considering e.coli
   and klebsiella, MRSA + and s. aureus on BAL and discontinue flagyl
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos.
   - f/u RUQ Doppler of PV and HV
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and likely underlying pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:  [**Last Name (LF) **], [**First Name3 (LF) **]
   Stress ulcer: lansoprazole
   VAP:  HOB elevation
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum and vancomycin considering e.coli
   and klebsiella, MRSA + and s. aureus on BAL and discontinue flagyl
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos.
   - f/u RUQ Doppler of PV and HV
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and likely underlying pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:  [**Last Name (LF) **], [**First Name3 (LF) **]
   Stress ulcer: lansoprazole
   VAP:  HOB elevation
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 81-year-old woman admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. She has developed several medical complications, including:

1. Septic Shock: The patient's hypotension persists despite treatment with pressors, and she has a high risk of developing further complications.
2. Hypoxic Respiratory Failure: The patient has a large pleural effusion and likely underlying pneumonia, which is contributing to her hypoxia.
3. Metabolic Acidosis: The patient's lactic acid levels are elevated, and her metabolic acidosis is likely due to sepsis.
4. Elevated Liver Function Tests (LFTs): The patient's LFTs are elevated, likely due to superimposed shock liver caused by poor distal perfusion.
5. Acute Renal Failure: The patient has anuric renal failure, likely due to hemodynamic instability.
6. Bilateral Pleural Effusions: The patient has a large left-sided pleural effusion, which is contributing to her hypoxia.
7. Atrial Fibrillation: The patient is in atrial fibrillation with rapid ventricular response, which may be contributing to her hypotension.
8. Diastolic Heart Failure: The patient has evidence of diastolic heart failure, which is being managed with careful fluid management and avoidance of vasodilators.

The patient is being treated with broad-spectrum antibiotics, including meropenem and vancomycin, and is being managed with pressors to maintain a mean arterial pressure (MAP) greater than 65 mmHg. She is also being treated with lactate-lowering agents and is being closely monitored for signs of septic shock.

The patient's laboratory results show elevated levels of white blood cells, lactate, and liver enzymes, as well as an elevated creatinine level. Her blood cultures are pending, and she has a positive urine culture for E. coli and Klebsiella. Her imaging studies show evidence of bilateral pleural effusions and consolidation/atelectasis in the lungs.

The patient's medical team is planning to perform a MRCP to evaluate her biliary tree and rule out obstruction. She is also being considered for hemodialysis or continuous venovenous hemofiltration (CVVH) due to her anuric renal failure."
174373.0,234940,2181-10-16 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is an 81-year-old female admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. She is currently in septic shock, requiring pressors to maintain a mean arterial pressure (MAP) above 65 mmHg. The patient has a history of urosepsis, pneumonia, cholangitis, and line infection, and is being treated with broad-spectrum antibiotics.

The patient has developed several complications, including:

1. Hypoxic respiratory failure: The patient has a large pleural effusion and is currently ventilated on ARDS net protocol, with possible underlying pneumonia.
2. Metabolic acidosis: The patient has lactic acidosis, which is likely due to septic shock, and is being treated with broad-spectrum antibiotics and pressors.
3. Elevated liver enzymes: The patient has elevated liver enzymes, which may be due to component of superimposed shock liver given poor distal perfusion.
4. Acute renal failure: The patient has anuric renal failure, likely due to hemodynamic origin, and is being considered for hemodialysis or continuous venovenous hemofiltration (CVVH).
5. Bilateral pleural effusions: The patient has bilateral pleural effusions, which may be contributing to hypoxia.
6. Atrial fibrillation: The patient is currently in atrial fibrillation with rapid ventricular response, and is being managed with pressors and rate control measures.
7. Diastolic heart failure: The patient has diastolic heart failure, and is being managed with fluid boluses and pressors.

Potential medical complications that may arise include:

1. Worsening septic shock: The patient's septic shock may worsen if not properly managed, leading to further hemodynamic instability and organ dysfunction.
2. Respiratory failure: The patient's hypoxic respiratory failure may worsen if not properly managed, leading to further respiratory compromise and potential need for mechanical ventilation.
3. Renal failure: The patient's anuric renal failure may worsen if not properly managed, leading to further electrolyte disturbances and potential need for dialysis.
4. Hepatic failure: The patient's elevated liver enzymes may indicate potential hepatic failure, which could lead to further organ dysfunction and potential need for liver transplantation.
5. Cardiovascular complications: The patient's atrial fibrillation and diastolic heart failure may lead to further cardiovascular complications, such as heart failure or cardiac arrest.
6. Infection: The patient's septic shock may be caused by a variety of infectious sources, including urosepsis, pneumonia, cholangitis, and line infection, which could lead to further infection and potential need for surgical intervention.
7. Nutritional deficiencies: The patient's poor nutritional status may worsen if not properly managed, leading to further malnutrition and potential need for nutritional support.

Based on this information, I recommend close monitoring of the patient's condition, with frequent assessments of her hemodynamic stability, respiratory function, renal function, and liver enzymes. Additionally, I recommend consideration of further diagnostic tests, such as a CT scan of the abdomen and pelvis, to rule out any potential sources of sepsis."
174373.0,234940,2181-10-16 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - blood cultures sent
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors, possible infectious
   sources include urosepsis, pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   - empiric ABX
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - blood cultures sent
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors, possible infectious
   sources include urosepsis, pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   - empiric ABX
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 81-year-old woman admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. She has been treated with broad-spectrum antibiotics, including meropenem, flagyl, and vancomycin, and has shown some improvement in her condition. However, she continues to experience hypotension, hypoxia, and acute kidney injury. She has also developed bilateral pleural effusions, atrial fibrillation, and diastolic heart failure.

Potential Medical Complications:

1. Sepsis-related organ dysfunction: The patient's sepsis has led to the development of multiple organ dysfunction, including acute kidney injury, liver dysfunction, and respiratory failure.
2. Infection-related complications: The patient's infections, including urosepsis, pneumonia, and cholangitis, could lead to further complications, such as abscesses, empyema, or septic shock.
3. Hypoxia-related complications: The patient's hypoxia could lead to respiratory failure, which could require mechanical ventilation.
4. Acute kidney injury-related complications: The patient's acute kidney injury could lead to further complications, such as electrolyte imbalances, acidosis, or the need for renal replacement therapy.
5. Liver dysfunction-related complications: The patient's liver dysfunction could lead to further complications, such as coagulopathy, encephalopathy, or the need for liver transplantation.
6. Heart failure-related complications: The patient's diastolic heart failure could lead to further complications, such as pulmonary edema, cardiogenic shock, or the need for heart transplantation.
7. Atrial fibrillation-related complications: The patient's atrial fibrillation could lead to further complications, such as stroke, heart failure, or the need for cardioversion.
8. Pleural effusion-related complications: The patient's bilateral pleural effusions could lead to further complications, such as respiratory failure, pleurisy, or the need for thoracentesis.
9. Metabolic acidosis-related complications: The patient's metabolic acidosis could lead to further complications, such as electrolyte imbalances, arrhythmias, or the need for bicarbonate therapy.

Given the patient's complex medical condition, it is essential to closely monitor her condition and adjust her treatment plan accordingly to prevent or manage these potential complications."
174373.0,234940,2181-10-17 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS/septic shock, continued hypotension on pressors
   (vasopressin and phenylephrine), infectious source likely MRSA
   pneumonia vs urosepsis
    -urine growing e.coli and enterococcus (no sensitivties yet, <10,000
   growing). BAL growing MRSA.
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone pending enterococcus sensitivities..
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction (too sick for ERCP, has pacer and can
t get MRCP)
 LFT
s now trending down likely representing component of superimposed
   shock liver given poor distal perfusion- INR and tbili continue to
   trend up.
   - appreciate liver and ERCP recs
   - liver workup negative
negative hepatitis, AMA, [**Doctor First Name **], etc.
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - will start dig today (renally dosed)
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS/septic shock, continued hypotension on pressors
   (vasopressin and phenylephrine), infectious source likely MRSA
   pneumonia vs urosepsis
    -urine growing e.coli and enterococcus (no sensitivties yet, <10,000
   growing). BAL growing MRSA.
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone pending enterococcus sensitivities..
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction (too sick for ERCP, has pacer and can
t get MRCP)
 LFT
s now trending down likely representing component of superimposed
   shock liver given poor distal perfusion- INR and tbili continue to
   trend up.
   - appreciate liver and ERCP recs
   - liver workup negative
negative hepatitis, AMA, [**Doctor First Name **], etc.
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - will start dig today (renally dosed)
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old female admitted with progressive jaundice, hypotension, and hypothermia, likely representing sepsis. She has a history of MRSA pneumonia, urosepsis, and elevated liver function tests (LFTs). She is currently on pressors, including vasopressin and phenylephrine, to maintain a mean arterial pressure (MAP) of >65 mmHg. She has a large pleural effusion and underlying MRSA pneumonia, which is being treated with vancomycin. Her lactate level is trending down, and her metabolic acidosis is being managed with broad-spectrum antibiotics and adequate MAPs.

Potential Medical Complications:

1. Sepsis-related organ dysfunction: The patient's sepsis is likely causing organ dysfunction, including respiratory failure, acute kidney injury, and liver dysfunction.
2. MRSA pneumonia: The patient's MRSA pneumonia is a significant infection that requires aggressive treatment with vancomycin.
3. Urosepsis: The patient's urine culture growing E. coli and Enterococcus suggests urosepsis, which needs to be treated with antibiotics.
4. Lactic acidosis: The patient's lactic acidosis is likely related to her sepsis and requires close monitoring and management.
5. Coagulopathy: The patient's coagulopathy, as evidenced by her prolonged prothrombin time (PT) and international normalized ratio (INR), requires close monitoring and management.
6. Acute kidney injury: The patient's acute kidney injury is likely related to her sepsis and requires close monitoring and management.
7. Respiratory failure: The patient's respiratory failure, as evidenced by her need for mechanical ventilation, requires close monitoring and management.
8. Heart failure: The patient's heart failure, as evidenced by her atrial fibrillation and elevated cardiac enzymes, requires close monitoring and management.
9. Liver dysfunction: The patient's liver dysfunction, as evidenced by her elevated LFTs, requires close monitoring and management.
10. Nutritional deficiencies: The patient's nutritional deficiencies, as evidenced by her low albumin level, require close monitoring and management.

Recommendations:

1. Continue aggressive treatment of sepsis with broad-spectrum antibiotics and pressors.
2. Continue treatment of MRSA pneumonia with vancomycin.
3. Treat urosepsis with antibiotics.
4. Monitor and manage lactic acidosis closely.
5. Monitor and manage coagulopathy closely.
6. Monitor and manage acute kidney injury closely.
7. Monitor and manage respiratory failure closely.
8. Monitor and manage heart failure closely.
9. Monitor and manage liver dysfunction closely.
10. Provide nutritional support to prevent nutritional deficiencies."
174373.0,234940,2181-10-17 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS, continued hypotension on pressors (vasopressin
   and phenylephrine), infectious source likely MRSA pneumonia vs E. coli
   urosepsis
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone.
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility and unlikely to be a bridge to better
   prognosis.
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS, continued hypotension on pressors (vasopressin
   and phenylephrine), infectious source likely MRSA pneumonia vs E. coli
   urosepsis
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone.
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility and unlikely to be a bridge to better
   prognosis.
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old female admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. She has a history of MRSA pneumonia and E. coli urosepsis, and is currently receiving broad-spectrum antibiotics. The patient has multiple medical complications, including respiratory failure, acute kidney injury, metabolic acidosis, atrial fibrillation, and diastolic heart failure.

Potential Medical Complications:

1. Sepsis: The patient's sepsis is likely to worsen if not adequately treated, leading to organ dysfunction and potentially life-threatening complications.
2. Respiratory Failure: The patient's respiratory failure may progress, requiring invasive mechanical ventilation and potentially leading to respiratory arrest.
3. Acute Kidney Injury: The patient's acute kidney injury may worsen, requiring dialysis and potentially leading to chronic kidney disease.
4. Metabolic Acidosis: The patient's metabolic acidosis may progress, leading to further organ dysfunction and potentially life-threatening complications.
5. Atrial Fibrillation: The patient's atrial fibrillation may worsen, leading to heart failure and potentially life-threatening complications.
6. Diastolic Heart Failure: The patient's diastolic heart failure may worsen, leading to further cardiac dysfunction and potentially life-threatening complications.
7. Liver Dysfunction: The patient's liver dysfunction may worsen, leading to further organ dysfunction and potentially life-threatening complications.
8. Bloodstream Infection: The patient's bloodstream infection may worsen, leading to sepsis and potentially life-threatening complications.
9. SIRS: The patient's SIRS may worsen, leading to further organ dysfunction and potentially life-threatening complications.

Recommendations:

1. Continue broad-spectrum antibiotics to treat sepsis and pneumonia.
2. Monitor and manage respiratory failure with invasive mechanical ventilation if necessary.
3. Monitor and manage acute kidney injury with dialysis if necessary.
4. Monitor and manage metabolic acidosis with aggressive treatment of underlying causes.
5. Monitor and manage atrial fibrillation with rate control and potentially cardioversion.
6. Monitor and manage diastolic heart failure with diuretics and potentially vasodilators.
7. Monitor and manage liver dysfunction with liver function tests and potentially liver transplantation.
8. Monitor and manage bloodstream infection with antibiotic therapy and potentially removal of central lines.
9. Monitor and manage SIRS with aggressive treatment of underlying causes and potentially corticosteroids."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old female admitted to the ICU with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. The patient has a complex medical condition with multiple organ dysfunction.

Potential medical complications that can arise include:

1. Sepsis-related organ failure: The patient's sepsis can lead to further organ dysfunction, such as acute kidney injury, liver failure, or respiratory failure.
2. Septic shock: The patient's persistent hypotension and need for pressors (phenylephrine) suggest the possibility of septic shock, which can lead to multi-organ failure and death if not treated promptly and effectively.
3. Respiratory failure: The patient's large effusion and underlying MRSA pneumonia may lead to worsening respiratory failure, requiring mechanical ventilation and potentially extracorporeal membrane oxygenation (ECMO).
4. Acute kidney injury: The patient's anuric renal failure may progress to acute kidney injury, requiring hemodialysis and potentially affecting the patient's overall prognosis.
5. Metabolic acidosis: The patient's lactic acidosis may worsen if not treated promptly, leading to further organ dysfunction and potentially life-threatening complications.
6. Atrial fibrillation: The patient's ongoing atrial fibrillation may lead to further cardiac complications, such as heart failure or stroke, if not managed effectively.
7. Intrahepatic cholestasis: The patient's persistent elevated liver enzymes and bilirubin levels may indicate ongoing intrahepatic cholestasis, which can lead to further liver dysfunction and potentially liver failure.
8. Coagulopathy: The patient's elevated INR and potential bleeding risk may require close monitoring and treatment to prevent bleeding complications.

To mitigate these potential complications, the patient requires close monitoring and aggressive treatment of her underlying sepsis, respiratory failure, and other organ dysfunction."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is an 81-year-old female admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. The patient has a complex medical condition with multiple potential complications.

The patient has been diagnosed with septic shock, MRSA pneumonia, and urosepsis. She is receiving pressor support with phenylephrine and antibiotics, including meropenem and vancomycin. The patient has a large pleural effusion and underlying MRSA pneumonia, which is being treated with pressure support ventilation and vancomycin.

The patient has acute renal failure, likely due to poor perfusion, and is being considered for CVVH and bridge to HD long-term. She has metabolic acidosis, likely due to lactic acidosis, and is being treated with broad-spectrum antibiotics and adequate MAPs.

The patient has atrial fibrillation and is being monitored for digoxin dosing. She has diastolic heart failure and is being held on beta-blockers and lasix due to hemodynamic instability. The patient has diffuse anasarca and is being repleted with electrolytes as needed.

Potential medical complications that can arise from the patient's condition include:

1. Worsening septic shock: The patient's septic shock can worsen if not properly managed, leading to further hypotension, organ dysfunction, and increased mortality.
2. Respiratory failure: The patient's underlying MRSA pneumonia and large pleural effusion can worsen, leading to respiratory failure and the need for mechanical ventilation.
3. Acute kidney injury: The patient's acute renal failure can worsen, leading to further kidney damage and the need for dialysis.
4. Metabolic acidosis: The patient's metabolic acidosis can worsen, leading to further organ dysfunction and increased mortality.
5. Cardiac complications: The patient's atrial fibrillation and diastolic heart failure can worsen, leading to cardiac complications such as cardiac arrest or cardiogenic shock.
6. Infections: The patient is at risk for further infections, including ventilator-associated pneumonia, central line-associated bloodstream infections, and catheter-associated urinary tract infections.
7. Hemodynamic instability: The patient's hemodynamic instability can worsen, leading to further organ dysfunction and increased mortality.

In conclusion, the patient is at high risk for multiple medical complications, and close monitoring and management are necessary to prevent and treat these complications."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - patient transitioned to PSV all day
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - patient transitioned to PSV all day
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old female with a history of progressive painless jaundice for two weeks, presenting with hypotension and hypothermia likely representing sepsis in the setting of MRSA pneumonia and urosepsis.

The patient has been loaded with digoxin with a level of 1.6 and has been transitioned to pressure support ventilation (PSV) all day. She is awaiting discussion with her family regarding the use of continuous venovenous hemofiltration (CVVH) and goals of care.

The patient's vital signs include a temperature of 36.9C (98.4F), heart rate of 116 beats per minute, blood pressure of 90/51 mmHg, respiratory rate of 16 breaths per minute, and oxygen saturation of 94%. She has atrial fibrillation and a central venous pressure of 7 mmHg.

The patient's laboratory results include a white blood cell count of 20.7, hemoglobin of 10.5 g/dL, platelet count of 153 K/uL, and creatinine of 2.8 mg/dL. Her liver function tests (LFTs) are elevated, with an aspartate aminotransferase (AST) of 640 IU/L, alanine aminotransferase (ALT) of 567 IU/L, and alkaline phosphatase (ALP) of 739 IU/L.

The patient's imaging studies include a chest X-ray (CXR) showing persistent asymmetric airspace opacification in the left perihilar region, slightly improved aeration at the right base, and bilateral pleural effusions. Her urine culture is positive for E. coli and Enterococcus, and her blood culture is pending.

The patient's medical conditions include septic shock, hypoxic respiratory failure, elevated LFTs, acute renal failure, metabolic acidosis, atrial fibrillation, and diastolic heart failure. She has been prescribed meropenem and vancomycin to cover MRSA, E. coli, and Enterococcus, and she is receiving pressor support with phenylephrine.

Potential medical complications that may arise include:

1. Progression of septic shock: The patient's septic shock may worsen if her underlying infections are not adequately treated, leading to further hypotension, organ dysfunction, and mortality.
2. Respiratory failure: The patient's hypoxic respiratory failure may worsen if her respiratory support is not optimized, leading to further hypoxia, respiratory acidosis, and mortality.
3. Acute kidney injury: The patient's acute renal failure may worsen if her underlying kidney dysfunction is not managed, leading to further azotemia, electrolyte imbalance, and mortality.
4. Metabolic acidosis: The patient's metabolic acidosis may worsen if her lactate levels continue to rise, leading to further acidosis, electrolyte imbalance, and mortality.
5. Atrial fibrillation: The patient's atrial fibrillation may worsen if her underlying heart disease is not managed, leading to further cardiac dysfunction, stroke, and mortality.
6. Diastolic heart failure: The patient's diastolic heart failure may worsen if her underlying heart disease is not managed, leading to further cardiac dysfunction, pulmonary edema, and mortality.

In conclusion, the patient is a high-risk individual with multiple medical conditions and complications. Close monitoring and management of her septic shock, respiratory failure, acute kidney injury, metabolic acidosis, atrial fibrillation, and diastolic heart failure are essential to prevent further deterioration and mortality."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w family concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy but
   may start if INR continues to trend down
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w family concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy but
   may start if INR continues to trend down
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old female admitted to the ICU with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. She has MRSA pneumonia, urosepsis, and E. Coli and Enterococcus in her urine. She is in septic shock requiring pressor support, has acute renal failure, metabolic acidosis, atrial fibrillation, and diastolic heart failure. She is also experiencing elevated liver function tests and has a large pleural effusion.

Potential Medical Complications:

1. Worsening of septic shock: The patient's blood pressure remains low, and she requires continued pressor support. This increases the risk of organ dysfunction and failure.
2. Respiratory failure: The patient's respiratory status is compromised, and she requires pressure support ventilation. There is a risk of further deterioration and potential need for intubation.
3. Acute kidney injury: The patient's renal function is compromised, and she is at risk of further deterioration and potential need for dialysis.
4. Metabolic acidosis: The patient's metabolic acidosis is likely due to lactic acidosis and may worsen if not addressed.
5. Atrial fibrillation: The patient's atrial fibrillation is likely to continue, and there is a risk of further cardiac complications, such as heart failure or stroke.
6. Liver failure: The patient's liver function tests are elevated, and there is a risk of further liver damage and potential need for liver transplantation.
7. Pleural effusion: The patient's large pleural effusion may worsen and potentially lead to respiratory compromise or cardiac tamponade.
8. Infection: The patient's MRSA pneumonia and urosepsis may worsen, and there is a risk of secondary infections, such as ventilator-associated pneumonia.
9. Hemodynamic instability: The patient's hemodynamic instability may worsen, and there is a risk of further organ dysfunction and failure.
10. Poor nutritional status: The patient's poor nutritional status may worsen, and there is a risk of further weight loss and potential need for parenteral nutrition."
174373.0,234940,2181-10-19 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   General: NAD, intubated, unresponsive, off sedation
   Heart: irregular, tachycardic, no MRG
   Lungs: coarse breath sounds bilateral anterolateral fields
   Abdomen: soft, ND, ABS
   Extremities: 4+ peripheral edema, weeping skin, WWP, CR < 1s
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-3**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - f/u urine sediment
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   General: NAD, intubated, unresponsive, off sedation
   Heart: irregular, tachycardic, no MRG
   Lungs: coarse breath sounds bilateral anterolateral fields
   Abdomen: soft, ND, ABS
   Extremities: 4+ peripheral edema, weeping skin, WWP, CR < 1s
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-3**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - f/u urine sediment
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old woman with a history of atrial fibrillation, diastolic heart failure, and recent cholecystectomy. She was hospitalized for ESBL Klebsiella UTI and later transferred to the ICU for further work-up of liver function test abnormalities.

Current condition:

* The patient is in atrial fibrillation with rapid ventricular rate, requiring vasopressin support.
* She has septic shock, with a possible source of infection from the urinary or lung.
* She has bilateral large pleural effusions and underlying MRSA pneumonia.
* She has acute renal failure, likely hemodynamic in origin, and is at risk of developing chronic kidney disease.
* She has diffuse anasarca with weeping skin and significant risk of skin sloughing.
* She has elevated liver function tests, including alkaline phosphatase, bilirubin, and lactate dehydrogenase, indicating intrahepatic cholestasis.

Potential medical complications:

1. Worsening septic shock: The patient's septic shock may worsen if not adequately treated, leading to organ dysfunction and potential mortality.
2. Respiratory failure: The patient's bilateral pleural effusions and underlying MRSA pneumonia may worsen her respiratory status, leading to hypoxia and respiratory failure.
3. Acute kidney injury: The patient's acute renal failure may progress to chronic kidney disease if not managed appropriately.
4. Skin sloughing: The patient's diffuse anasarca and weeping skin may lead to skin sloughing, which can be a source of infection and further complications.
5. Intrahepatic cholestasis: The patient's intrahepatic cholestasis may worsen if not managed appropriately, leading to liver dysfunction and potential liver failure.
6. Atrial fibrillation: The patient's atrial fibrillation may worsen if not managed appropriately, leading to heart failure and potential mortality.

Plan:

* Continue vasopressin support to maintain mean arterial pressure > 65 mmHg.
* Continue meropenem and vancomycin for suspected urinary or lung source of sepsis.
* Continue digoxin for atrial fibrillation.
* Consider restarting anticoagulation for atrial fibrillation.
* Monitor liver function tests and consider ERCP if the patient becomes more stable.
* Monitor renal function and consider dialysis if necessary.
* Monitor skin condition and provide wound care recommendations.
* Consider fentanyl boluses to treat atrial fibrillation with rapid ventricular rate.
* Continue to trend INR and consider restarting anticoagulation for atrial fibrillation.
* Consider extubation if the patient's respiratory status improves.
* Consider CVVH and bridge to long-term HD to define goals of care.
* Continue to monitor and manage the patient's septic shock, respiratory failure, and other complications."
174373.0,234940,2181-10-19 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV and consider SBT
 d/w family possible CMO with trial
   of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 and dosed per levels
   - f/u lytes
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV and consider SBT
 d/w family possible CMO with trial
   of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 and dosed per levels
   - f/u lytes
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old female with a history of atrial fibrillation, diastolic heart failure, and a recent hospitalization for an ESBL Klebsiella UTI. She was transferred to the ICU for further work-up of liver function test (LFT) abnormalities. The patient has been diagnosed with intrahepatic cholestasis and sepsis from a urinary or lung source, with ongoing atrial fibrillation with rapid ventricular response (RVR) and worsening renal function.

The patient's current condition is complicated by:

1. Septic shock: requiring vasopressin support, with MRSA pneumonia or urosepsis as the potential infectious source.
2. Hypoxic respiratory failure: with bilateral large effusions and underlying MRSA pneumonia.
3. Elevated LFT: with AST/ALT trending down, but AP/LDH and TBili remaining constant, indicating intrahepatic cholestasis.
4. Acute renal failure: likely hemodynamic in origin, with poor perfusion.
5. Atrial fibrillation: with RVR, and a recent digoxin load.
6. Skin: diffuse anasarca with weeping skin and significant risk of skin sloughing.
7. Diastolic heart failure: with hemodynamic instability.

Potential medical complications that may arise include:

1. Worsening septic shock: leading to further organ dysfunction and potentially life-threatening consequences.
2. Pneumonia progression: with MRSA pneumonia, there is a risk of further lung damage and potential respiratory failure.
3. Renal failure: with acute kidney injury, there is a risk of chronic kidney disease and potential need for long-term dialysis.
4. Liver failure: with intrahepatic cholestasis, there is a risk of liver failure and potential need for liver transplantation.
5. Skin breakdown: with diffuse anasarca and weeping skin, there is a risk of skin sloughing and potential infection.
6. Atrial fibrillation: with ongoing RVR, there is a risk of stroke and potential need for anticoagulation.
7. Cardiovascular instability: with diastolic heart failure and ongoing atrial fibrillation, there is a risk of cardiovascular collapse and potential need for further cardiac intervention."
174373.0,234940,2181-10-20 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-1**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-1**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications can be identified:

**Summary:**

The patient is a 81-year-old male admitted to the ICU with intrahepatic cholestasis, sepsis, and atrial fibrillation. He is currently in septic shock, requiring vasopressin support, and has worsening renal function. He has bilateral large pleural effusions, MRSA pneumonia, and intrahepatic cholestasis. He is also experiencing hypoxic respiratory failure, elevated liver function tests, and acute renal failure.

**Potential Medical Complications:**

1. **Sepsis and Septic Shock:** The patient's septic shock may worsen if not properly managed, leading to organ dysfunction and potentially life-threatening complications.
2. **Acute Renal Failure:** The patient's acute renal failure may progress to chronic kidney disease or require renal replacement therapy if not managed promptly.
3. **Atrial Fibrillation:** The patient's atrial fibrillation may lead to cardiac complications, such as stroke or heart failure, if not managed with anticoagulation therapy.
4. **Hepatic Failure:** The patient's intrahepatic cholestasis may worsen and lead to hepatic failure if not managed with proper treatment.
5. **Pneumonia:** The patient's MRSA pneumonia may worsen and lead to respiratory failure or septicemia if not properly managed with antibiotics.
6. **Skin Complications:** The patient's diffuse anasarca and weeping skin may lead to skin sloughing or infections if not properly managed with wound care and prophylactic antibiotics.
7. **Respiratory Failure:** The patient's hypoxic respiratory failure may worsen and lead to respiratory arrest or chronic respiratory disease if not properly managed with mechanical ventilation and oxygen therapy.
8. **Cardiac Complications:** The patient's diastolic heart failure may worsen and lead to cardiac arrest or heart failure if not properly managed with medications and fluid management.
9. **Electrolyte Imbalance:** The patient's anuria and diffuse anasarca may lead to electrolyte imbalances, such as hyperkalemia or hypokalemia, if not properly managed with electrolyte supplementation.
10. **Infection:** The patient's sepsis and pneumonia may lead to secondary infections, such as ventilator-associated pneumonia or central line-associated bloodstream infection, if not properly managed with antibiotic therapy and infection control measures."
174373.0,234940,2181-10-20 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
         [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
         [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 81-year-old male with a complex medical condition, including:

1. Atrial Fibrillation (AFib) with RVR, which is ongoing and requires continued treatment with digoxin.
2. Renal failure, acute (ARF), likely caused by poor perfusion and hemodynamic instability.
3. Sepsis, severe, with organ dysfunction, likely caused by MRSA pneumonia or urosepsis.
4. Respiratory failure, acute, with bilateral large effusions and underlying MRSA pneumonia.
5. Metabolic acidosis, likely caused by sepsis and ARF.
6. Hypothermia, which requires continued treatment with vasopressin support.
7. Impaired skin integrity, with diffuse anasarca and weeping skin, which requires wound care recommendations.
8. Diastolic heart failure, which requires continued holding of beta-blockers and Lasix due to hemodynamic instability.
9. FEN (Fenoldopam) is being held due to anuria with diffuse anasarca, and electrolytes need to be repleted as needed.

The patient's laboratory results show:

* Elevated LFTs (AST/ALT) with a trend towards normalization, indicating intrahepatic cholestasis.
* Elevated bilirubin levels, indicating liver dysfunction.
* Elevated lactate levels, indicating metabolic acidosis.
* Elevated troponin-T levels, indicating cardiac injury.

The patient's imaging studies show:

* CXR (chest X-ray) with increasing perihilar opacification in the left lung, likely due to resolving edema or redistribution of pleural fluid.
* Moderate right pleural effusion, which is stable.

The patient's microbiology results show:

* Positive blood culture for MRSA.
* Positive urine culture for E. coli and Enterococcus.
* Positive bronchoalveolar lavage (BAL) culture for Staphylococcus aureus.

The patient's medication list includes:

* Meropenem for E. coli and Enterococcus.
* Vancomycin for MRSA pneumonia.
* Digoxin for AFib.
* Fentanyl for pain management.
* Vasopressin for septic shock.
* PPI for stress ulcer prophylaxis.

The patient's care plan includes:

* Continuing meropenem and vancomycin.
* Continuing pressor support to maintain MAP > 65.
* Continuing digoxin for AFib.
* Attempting spontaneous breathing trial (SBT) today.
* Considering ERCP if the patient becomes more stable.
* Trending LFTs and considering restarting anticoagulation for atrial fibrillation.
* F/u wound care recommendations for skin integrity.
* Holding IVF due to anuria with diffuse anasarca.

Potential medical complications that can arise include:

* Further deterioration of renal function.
* Worsening of respiratory failure.
* Development of cardiac arrhythmias.
* Increased risk of skin sloughing and infection.
* Continued septic shock.
* Metabolic acidosis.
* Liver dysfunction.
* Cardiac injury.

The patient's code status is DNR/DNI, and the disposition is ICU."
174373.0,234940,2181-10-21 07:20:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: edematous
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
    # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: edematous
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
    # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the information and potential medical complications that can arise:

**Current Status:**

* The patient is a 81-year-old male with intrahepatic cholestasis and sepsis from an unknown source, with atrial fibrillation and worsening renal function.
* He is receiving vasopressin support for septic shock and has MRSA pneumonia.
* His vital signs include a temperature of 36.6C, heart rate of 104 bpm, and blood pressure of 104/53 mmHg.
* He has a respiratory rate of 22 breaths per minute, with an oxygen saturation of 99% on 50% FiO2.
* His laboratory results show acute kidney injury, liver dysfunction, and elevated lactate levels.

**Potential Medical Complications:**

* **Renal Failure:** The patient's worsening renal function and acute kidney injury increase the risk of further deterioration in renal function, potentially leading to end-stage renal disease.
* **Sepsis:** The patient's ongoing septic shock and presence of MRSA pneumonia increase the risk of further organ dysfunction and mortality.
* **Atrial Fibrillation:** The patient's atrial fibrillation with rapid ventricular response (RVR) increases the risk of cardiac arrhythmias, heart failure, and stroke.
* **Hypotension:** The patient's hypotension and vasopressor dependence increase the risk of further hypotension, organ dysfunction, and mortality.
* **Acidosis:** The patient's metabolic acidosis increases the risk of further acidosis, organ dysfunction, and mortality.
* **Skin Complications:** The patient's diffuse anasarca and weeping skin increase the risk of skin sloughing, infections, and further complications.
* **Liver Dysfunction:** The patient's ongoing liver dysfunction increases the risk of further liver damage, coagulopathy, and mortality.
* **Respiratory Failure:** The patient's respiratory failure and bilateral large effusions increase the risk of further respiratory compromise, hypoxia, and mortality.

**Recommendations:**

* Continue aggressive management of septic shock with vasopressin support and antibiotics.
* Monitor the patient's renal function closely and consider renal replacement therapy if necessary.
* Continue to manage atrial fibrillation with digoxin and consider restarting anticoagulation.
* Monitor the patient's skin condition closely and consider wound care recommendations.
* Continue to manage liver dysfunction and consider ERCP if the patient becomes more stable.
* Monitor the patient's respiratory function closely and consider non-invasive ventilation or intubation if necessary.
* Consider fentanyl boluses to treat atrial fibrillation RVR."
174373.0,234940,2181-10-21 07:20:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT yesterday-->did well, good sats, but tired out and
   became tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear to be rising
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharmacy. Will check level
   this morning. Could consider dc dig as does not seem to be helping her
   rate at all
   - continue to trend INR now 2.0
 could consider restarting
   anticoagulation for atrial fibrillation
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR (chemical code ok)
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT yesterday-->did well, good sats, but tired out and
   became tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear to be rising
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharmacy. Will check level
   this morning. Could consider dc dig as does not seem to be helping her
   rate at all
   - continue to trend INR now 2.0
 could consider restarting
   anticoagulation for atrial fibrillation
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR (chemical code ok)
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old female with intrahepatic cholestasis and sepsis from urinary or lung source, continuing atrial fibrillation with RVR and worsening renal function. She has acute respiratory failure, metabolic acidosis, and hypotension. She is on vasopressin support and has MRSA pneumonia and urosepsis as potential infective sources. Her laboratory results show acute renal failure, liver function abnormalities, and electrolyte imbalances.

Potential Medical Complications:

1. Progression of Acute Respiratory Failure: The patient's respiratory status is critical, and further deterioration may occur, leading to respiratory failure and potential need for mechanical ventilation.
2. Worsening Renal Function: The patient's renal function is already compromised, and further decline may lead to end-stage renal disease or require dialysis.
3. Infection Progression: The patient's MRSA pneumonia and urosepsis may worsen, leading to septic shock, organ dysfunction, or death.
4. Cardiac Complications: The patient's atrial fibrillation may lead to cardiac arrhythmias, heart failure, or stroke.
5. Gastrointestinal Complications: The patient's liver function abnormalities may lead to gastrointestinal bleeding, ascites, or encephalopathy.
6. Skin Complications: The patient's diffuse anasarca and weeping skin may lead to skin sloughing, infection, or other complications.
7. Hypothermia: The patient's hypothermia may worsen, leading to decreased cardiac output, increased risk of arrhythmias, and other complications.
8. Metabolic Acidosis: The patient's metabolic acidosis may worsen, leading to organ dysfunction, cardiac complications, or death.

Recommendations:

1. Continue vasopressor support to maintain MAP > 65.
2. Monitor and adjust antibiotic therapy to address MRSA pneumonia and urosepsis.
3. Consider ERCP if the patient becomes more stable to evaluate and treat intrahepatic cholestasis.
4. Monitor and adjust digoxin therapy to manage atrial fibrillation.
5. Continue wound care recommendations to prevent skin sloughing and infection.
6. Monitor and adjust electrolyte levels to prevent further complications.
7. Consider restarting anticoagulation therapy for atrial fibrillation.
8. Continue to trend liver function tests and consider further interventions if necessary."
174373.0,234940,2181-10-21 07:20:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 81-year-old male with intrahepatic cholestasis and sepsis from urinary or lung source, continuing atrial fibrillation with RVR and worsening renal function. He is in septic shock requiring vasopressin support with MRSA pneumonia vs. urosepsis as the infective source. He has acute renal failure, likely ATN due to poor perfusion, and elevated liver function tests (LFT) with intrahepatic cholestasis. He also has atrial fibrillation, diastolic heart failure, and diffuse anasarca with weeping skin and significant risk of skin sloughing.

Potential Medical Complications:

1. Progression of septic shock: The patient is at risk of worsening septic shock due to the ongoing infection and potential organ dysfunction.
2. Acute kidney injury: The patient's renal function is worsening, and he is at risk of developing acute kidney injury (AKI) or chronic kidney disease (CKD) if not managed properly.
3. Respiratory failure: The patient has acute respiratory failure, and his respiratory status may deteriorate if not managed properly.
4. Intrahepatic cholestasis: The patient's LFTs are elevated, and he is at risk of developing severe liver dysfunction if not managed properly.
5. Skin sloughing: The patient's diffuse anasarca and weeping skin make him at risk of skin sloughing, which can lead to serious complications such as sepsis and organ failure.
6. Atrial fibrillation: The patient's atrial fibrillation is poorly controlled, and he is at risk of developing cardiac arrhythmias or atrial flutter.
7. Diastolic heart failure: The patient has diastolic heart failure, and his cardiac function may deteriorate if not managed properly.
8. Malnutrition: The patient's anasarca and poor perfusion may lead to malnutrition, which can worsen his overall condition.
9. Electrolyte imbalance: The patient's anasarca and poor perfusion may lead to electrolyte imbalance, which can worsen his overall condition.
10. Infection: The patient has MRSA pneumonia and urosepsis, and he is at risk of developing further infections if not managed properly."
174373.0,234940,2181-10-22 07:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   - consider HIT Ig and pulling central line
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   - consider HIT Ig and pulling central line
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male admitted to the ICU with grossly abnormal liver function tests (LFTs), sepsis from a urinary tract infection (UTI) and MRSA pneumonia, and anuria. The patient has continued to deteriorate, with worsening thrombocytopenia, anuric renal failure, and persistent atrial fibrillation with rapid ventricular response (RVR). The patient's condition is complicated by intrahepatic cholestasis, septic shock, hypoxic respiratory failure, acute renal failure, and diffuse anasarca with weeping skin.

Potential Medical Complications:

1. Septic Shock: The patient's condition is complicated by septic shock, which is likely due to the MRSA pneumonia and UTI. The patient requires continued vasopressor support to maintain a mean arterial pressure (MAP) greater than 65 mmHg.
2. Acute Respiratory Distress Syndrome (ARDS): The patient's hypoxic respiratory failure and bilateral large effusions increase the risk of developing ARDS.
3. Acute Kidney Injury (AKI): The patient's anuric renal failure and rising creatinine levels indicate a high risk of developing AKI.
4. Hepatic Failure: The patient's intrahepatic cholestasis and elevated liver enzymes (ALT, AST, and alkaline phosphatase) increase the risk of developing hepatic failure.
5. Skin Sloughing: The patient's diffuse anasarca with weeping skin increases the risk of skin sloughing and wound complications.
6. Thrombotic Complications: The patient's thrombocytopenia and continued drop in platelet count increase the risk of thrombotic complications, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
7. Cardiac Complications: The patient's atrial fibrillation with RVR and diastolic heart failure increase the risk of cardiac complications, including heart failure, cardiogenic shock, and arrhythmias.
8. Infections: The patient's sepsis and pneumonia increase the risk of developing secondary infections, including ventilator-associated pneumonia (VAP) and central line-associated bloodstream infection (CLABSI).
9. Gastrointestinal Complications: The patient's anuria and diffuse anasarca increase the risk of gastrointestinal complications, including gastrointestinal bleeding and perforation.
10. Multisystem Organ Failure: The patient's severe sepsis and multi-organ dysfunction increase the risk of developing multisystem organ failure, which can lead to a poor prognosis."
174373.0,234940,2181-10-22 07:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old male with a history of atrial fibrillation, diastolic heart failure, and intrahepatic cholestasis. He was admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia. The patient is anuric and has been treated with antibiotics, vasopressin, and fentanyl.

The patient's current vital signs are:

* Temperature: 36.1C (96.9F)
* Heart rate: 126 bpm
* Blood pressure: 123/67 mmHg
* Respiratory rate: 19 breaths per minute
* Oxygen saturation: 99%

The patient has a platelet count of 59,000/L, which is rapidly dropping. The patient's liver function tests (LFTs) are abnormal, with an aspartate aminotransferase (AST) level of 156 IU/L and an alanine aminotransferase (ALT) level of 143 IU/L.

The patient has a history of atrial fibrillation and is currently in atrial fibrillation with rapid ventricular response (AFib with RVR). The patient has been treated with digoxin, but there has been no improvement in AFib with RVR.

The patient has a diffuse anasarca (swelling) with weeping skin and a significant risk of skin sloughing. The patient's electrolytes are abnormal, with a potassium level of 3.3 mEq/L and a magnesium level of 2.5 mg/dL.

The patient has been treated with antibiotics, vasopressin, and fentanyl, and is currently receiving a pressor to maintain a mean arterial pressure (MAP) of greater than 65 mmHg. The patient's urine output is anuric, and the patient has been treated with fluid boluses and vasopressin to maintain perfusion.

Potential medical complications that can arise from the patient's current condition include:

1. Sepsis: The patient's UTI and MRSA pneumonia are causing sepsis, which can lead to multi-organ dysfunction and death.
2. Acute kidney injury (AKI): The patient's anuric renal failure is likely due to ATN, which can lead to chronic kidney disease and end-stage renal disease.
3. Liver failure: The patient's intrahepatic cholestasis and abnormal LFTs can lead to liver failure, which can be life-threatening.
4. Cardiac complications: The patient's AFib with RVR can lead to cardiac arrhythmias, heart failure, and cardiac arrest.
5. Skin sloughing: The patient's diffuse anasarca and weeping skin can lead to skin sloughing, which can be a life-threatening complication.
6. Electrolyte imbalances: The patient's abnormal electrolyte levels can lead to cardiac arrhythmias, muscle weakness, and other complications.
7. Respiratory failure: The patient's pneumonia and anuric renal failure can lead to respiratory failure, which can be life-threatening.

In conclusion, the patient is a complex case with multiple medical complications. The patient requires close monitoring and aggressive management to prevent further complications and improve his clinical condition."
174373.0,234940,2181-10-22 07:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male admitted to the ICU with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia. He is anuric and has developed atrial fibrillation with rapid ventricular response (AFib with RVR). The patient's condition is complicated by thrombocytopenia, hypoxic respiratory failure, acute renal failure, and intrahepatic cholestasis.

Potential Medical Complications:

1. Septic Shock: The patient's septic shock is ongoing, and the source of the infection is still unclear. The patient's vasopressor support is being continued to maintain a mean arterial pressure (MAP) above 65 mmHg.
2. Acute Kidney Injury (AKI): The patient's creatinine level is rising, and he is at risk of developing AKI due to his anuric renal failure. CVVH and HD are being considered, but the family is hesitant due to concerns about long-term guardianship.
3. Thrombocytopenia: The patient's platelet count is rapidly dropping, and the causes of thrombocytopenia are being considered, including synthetic dysfunction, heparin-induced thrombocytopenia (HIT), splenic sequestration, and drug-induced thrombocytopenia.
4. Intrahepatic Cholestasis: The patient's LFTs are abnormal, and intrahepatic cholestasis is suspected. ERCP is being considered if the patient becomes more stable.
5. Atrial Fibrillation: The patient's AFib with RVR is ongoing, and digoxin is being titrated to effect. Increasing digoxin may be considered if the patient does not respond to the current dose.
6. Skin Complications: The patient has diffuse anasarca with weeping skin, which increases the risk of skin sloughing. Wound care recommendations are being followed.
7. Diastolic Heart Failure: The patient's diastolic heart failure is being managed by holding beta-blockers (BB) and lasix due to hemodynamic instability.
8. Respiratory Failure: The patient has hypoxic respiratory failure, which is being managed with antibiotics and limited IV fluids.
9. Shock Liver: The patient's liver enzymes are abnormal, and shock liver is suspected. The patient's liver function is being closely monitored.
10. Electrolyte Imbalance: The patient has an electrolyte imbalance, which is being managed with electrolyte repletion as needed.

Overall, the patient's condition is complex and requires close monitoring and management of multiple organ systems."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old individual with a history of atrial fibrillation and diastolic heart failure, admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. The patient is anuric, requiring vasopressin support to maintain mean arterial pressure (MAP) above 65 mmHg.

The patient's current condition is characterized by:

1. Septic shock state with ongoing MRSA pneumonia or urosepsis as the infectious source.
2. Hypoxic respiratory failure with bilateral large effusions and underlying MRSA pneumonia.
3. Acute renal failure, likely due to ATN, with a rising creatinine level of 4.5 mg/dL.
4. Thrombocytopenia, initially rapidly dropping platelet count, which has stabilized, likely representing drug-induced thrombocytopenia.
5. Elevated LFTs, including AST, ALT, AP, and LDH, indicating intrahepatic cholestasis or obstructive picture.
6. Atrial fibrillation with rapid ventricular response (RVR), controlled with digoxin.
7. Diffuse anasarca with weeping skin and significant risk of skin sloughing.
8. Diastolic heart failure, with hemodynamic instability and renal failure.

Potential medical complications that can arise from the patient's current condition include:

1. Further deterioration of renal function, leading to worsening anuria and electrolyte imbalance.
2. Increased risk of skin sloughing and pressure ulcers due to diffuse anasarca and weeping skin.
3. Development of liver failure or worsening intrahepatic cholestasis, potentially leading to coagulopathy and bleeding.
4. Progression of MRSA pneumonia to respiratory failure, requiring mechanical ventilation.
5. Increased risk of cardiac arrhythmias, including ventricular fibrillation or tachycardia, due to atrial fibrillation and underlying heart disease.
6. Development of septic shock complications, such as acute kidney injury, cardiac arrest, or disseminated intravascular coagulation (DIC).

Given the patient's complex condition, it is essential to closely monitor their vital signs, laboratory results, and clinical status to identify any potential complications early and adjust management accordingly."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the patient's current condition and potential medical complications:

**Current Condition:**

* The patient is an 81-year-old male with a history of atrial fibrillation, diastolic heart failure, and intrahepatic cholestasis.
* He is currently septic with E. coli and Enterococcus UTI, and MRSA pneumonia.
* He has anuria, renal failure, and is receiving vasopressin support for septic shock.
* He has bilateral large pleural effusions and underlying MRSA pneumonia.
* He has thrombocytopenia, elevated LFTs, and atrial fibrillation with rapid ventricular response.
* He has diffuse anasarca with weeping skin and significant risk of skin sloughing.

**Potential Medical Complications:**

1. **Renal Failure:** The patient's anuria and rising creatinine levels suggest that he may be at risk for acute tubular necrosis (ATN). Continuous renal replacement therapy (CRRT) or hemodialysis may be necessary to manage his renal failure.
2. **Septic Shock:** The patient's septic shock physiology requires ongoing vasopressor support to maintain a mean arterial pressure (MAP) > 65. Monitoring for signs of shock, such as decreased urine output, decreased blood pressure, and decreased peripheral perfusion, is essential.
3. **Atrial Fibrillation:** The patient's atrial fibrillation with rapid ventricular response requires ongoing rate control with digoxin. Close monitoring for signs of digoxin toxicity is necessary.
4. **Thrombocytopenia:** The patient's thrombocytopenia may be drug-induced, and monitoring for signs of bleeding is necessary. Platelet transfusions may be necessary if the platelet count continues to decline.
5. **Intrahepatic Cholestasis:** The patient's elevated LFTs suggest that he may have intrahepatic cholestasis or obstructive liver disease. A liver consultation is necessary to evaluate the patient's LFT abnormalities and consider imaging studies such as magnetic resonance cholangiopancreatography (MRCP) to evaluate for common bile duct obstruction.
6. **Pleural Effusions:** The patient's bilateral large pleural effusions may be contributing to his respiratory failure. Thoracentesis or chest tube placement may be necessary to drain the effusions and improve respiratory function.
7. **Skin Sloughing:** The patient's diffuse anasarca with weeping skin and significant risk of skin sloughing requires close monitoring for signs of skin breakdown and wound care recommendations.
8. **Respiratory Failure:** The patient's respiratory failure requires ongoing mechanical ventilation and oxygen therapy. Close monitoring for signs of respiratory failure, such as decreased oxygen saturation and increased respiratory rate, is necessary.

Overall, the patient is at high risk for multiple medical complications, and close monitoring and management are necessary to prevent or treat these complications."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old male admitted to the ICU with intrahepatic cholestasis and sepsis from a urinary or lung source. The patient has developed atrial fibrillation, septic shock, and acute renal failure with anuric renal failure.

The patient's vital signs are:

* Temperature: 36.1C (96.9F)
* Heart rate: 94 bpm
* Blood pressure: 107/53 mmHg
* Respiratory rate: 20 breaths per minute
* Oxygen saturation: 100%

The patient's laboratory results show:

* White blood cell count: 18.7 x 10^9/L
* Hemoglobin: 9.5 g/dL
* Platelet count: 73 x 10^9/L
* Creatinine: 4.1 mg/dL
* Blood urea nitrogen: 140 mg/dL
* Serum sodium: 141 mg/dL
* Serum potassium: 4.5 mg/dL
* Serum chloride: 112 mg/dL
* Serum bicarbonate: 16.3 mEq/L
* Serum albumin: 2.3 g/dL
* Lactic acid: 1.1 mmol/L

The patient's physical examination reveals:

* Bilateral large effusions
* Diffuse anasarca with weeping skin and significant risk of skin sloughing
* No peripheral vascular pulses assessed
* No skin lesions assessed
* Neurological examination is not assessed

The patient's medical conditions and potential complications include:

* Septic shock requiring vasopressin support
* Atrial fibrillation with rapid ventricular response
* Acute renal failure with anuric renal failure
* Thrombocytopenia
* Elevated liver function tests
* Intrahepatic cholestasis or obstructive picture
* Diffuse anasarca with weeping skin and significant risk of skin sloughing
* Diastolic heart failure
* FEN (fatty liver of unknown etiology)

The patient's treatment plan includes:

* Continue antibiotics (meropenem and vancomycin)
* Continue pressor support with vasopressin
* Limit IV fluids in setting of anuric renal failure
* Consider CVVH and HD for acute renal failure
* Trend platelets and consider antibiotic holiday with daily re-addition to evaluate for drug-induced thrombocytopenia
* Continue to trend liver function tests and consider ERCP if patient becomes more stable
* Consider increasing digoxin to control atrial fibrillation
* Hold beta-blockers and lasix due to hemodynamic instability
* Hold IV fluids due to anuria with diffuse anasarca and replete electrolytes as needed
* Provide wound care recommendations for diffuse anasarca with weeping skin and significant risk of skin sloughing

The patient's code status is DNR/DNI, and their disposition is ICU care."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. The patient is anuric and has been experiencing septic shock, requiring vasopressin support.

The patient has been treated with meropenem and vancomycin, and has shown some improvement in his respiratory status, with decreasing oxygen requirements and improved lung mechanics. However, he remains in atrial fibrillation and has developed significant peripheral edema and jaundice.

The patient's laboratory results show continued elevation of liver enzymes, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (AP), as well as a prolonged prothrombin time (PT) and partial thromboplastin time (PTT). His blood urea nitrogen (BUN) and creatinine (Cr) levels are elevated, indicating acute renal failure.

The patient's medical conditions and potential complications include:

1. Septic shock: The patient remains in septic shock, requiring vasopressin support, and has a high risk of developing further complications, such as multi-organ dysfunction syndrome (MODS).
2. Acute renal failure: The patient has developed acute renal failure, which may progress to chronic kidney disease (CKD) if not managed appropriately.
3. Thrombocytopenia: The patient has developed thrombocytopenia, which may be caused by the antibiotics or other medications, and may increase the risk of bleeding.
4. Intrahepatic cholestasis: The patient's liver function tests (LFTs) are abnormal, indicating intrahepatic cholestasis, which may be caused by the sepsis or other underlying conditions.
5. MRSA pneumonia: The patient has MRSA pneumonia, which may require further treatment and management.
6. Anuric renal failure: The patient is anuric, which may require further management, such as continuous renal replacement therapy (CRRT) or hemodialysis.
7. Diastolic heart failure: The patient has diastolic heart failure, which may worsen if not managed appropriately.
8. Skin complications: The patient has developed significant peripheral edema and jaundice, which may increase the risk of skin sloughing and other complications.
9. Atrial fibrillation: The patient remains in atrial fibrillation, which may increase the risk of stroke and other cardiovascular complications.

Based on the patient's condition, potential complications, and medical history, the following potential medical complications may arise:

1. Further progression of septic shock and MODS
2. Development of chronic kidney disease (CKD)
3. Increased risk of bleeding due to thrombocytopenia
4. Worsening of intrahepatic cholestasis and liver failure
5. Development of further skin complications, such as skin sloughing
6. Increased risk of cardiovascular complications, such as stroke and heart failure
7. Further progression of MRSA pneumonia and respiratory failure
8. Development of further anuric renal failure and electrolyte imbalances

In conclusion, the patient is at high risk of developing further complications, and close monitoring and management are necessary to prevent and treat these complications."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, who was admitted with grossly abnormal liver function tests (LFTs) and sepsis due to urinary tract infection (UTI) and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. The patient is currently anuric and has developed respiratory failure, requiring mechanical ventilation.

Potential medical complications that can arise from this patient's condition include:

1. Septic shock: The patient is already in septic shock, which can lead to further deterioration in his condition, including cardiac arrest, respiratory failure, and multi-organ dysfunction.
2. Acute tubular necrosis (ATN): The patient's rising creatinine levels and anuria suggest ATN, which can lead to chronic kidney disease or end-stage renal disease.
3. Intrahepatic cholestasis: The patient's persistent abnormal LFTs and bilirubin levels indicate intrahepatic cholestasis, which can lead to further liver damage and potentially life-threatening complications.
4. Thrombocytopenia: The patient's rapidly dropping platelet count increases the risk of bleeding complications, which can be exacerbated by the use of anticoagulant therapy.
5. Respiratory failure: The patient's underlying MRSA pneumonia and bilateral large effusions increase the risk of further respiratory deterioration, including ventilator-associated pneumonia and respiratory failure.
6. Skin complications: The patient's diffuse anasarca and weeping skin increase the risk of skin sloughing, which can lead to further complications, including sepsis and wound infection.
7. Atrial fibrillation: The patient's persistent atrial fibrillation increases the risk of stroke, cardiac arrest, and further cardiac complications.
8. Diastolic heart failure: The patient's underlying diastolic heart failure increases the risk of further cardiac deterioration, including cardiac arrest and heart failure exacerbation.

In terms of the patient's treatment plan, the following issues need to be addressed:

1. Antibiotic therapy: The patient is receiving meropenem and vancomycin, which should be continued to treat the underlying infections.
2. Vasopressor support: The patient requires ongoing vasopressor support to maintain his blood pressure and perfusion.
3. Renal replacement therapy: The patient's anuria and rising creatinine levels suggest the need for renal replacement therapy, including continuous venovenous hemofiltration (CVVH) and hemodialysis (HD).
4. Platelet count monitoring: The patient's rapidly dropping platelet count requires close monitoring and consideration of platelet transfusions.
5. Wound care: The patient's weeping skin and risk of skin sloughing require ongoing wound care and management.
6. Antibiotic holiday: The patient's thrombocytopenia and risk of bleeding complications suggest the need for an antibiotic holiday to evaluate for drug-induced thrombocytopenia.
7. Liver function testing: The patient's persistent abnormal LFTs require ongoing monitoring and consideration of liver function testing to evaluate for liver damage and potential liver failure.
8. Cardiac management: The patient's atrial fibrillation and diastolic heart failure require ongoing cardiac management, including consideration of rate control and rhythm management strategies."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, admitted to the ICU with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia, now in anuric renal failure. The patient has been treated with vancomycin and meropenem, and is currently receiving vasopressin support for septic shock. The patient's condition is complicated by thrombocytopenia, elevated LFTs, atrial fibrillation, and skin changes.

Potential Medical Complications:

1. Continued septic shock and potential for further organ dysfunction, including cardiac, renal, and hepatic failure.
2. Risk of skin sloughing and maceration due to diffuse anasarca and weeping skin.
3. Potential for further thrombocytopenia and bleeding complications.
4. Elevated LFTs and potential for liver failure or obstructive jaundice.
5. Atrial fibrillation and potential for further cardiac complications.
6. Anuric renal failure and potential for further kidney damage or failure.
7. Risk of VAP and DVT due to prolonged mechanical ventilation and immobility.
8. Potential for further electrolyte imbalances and acid-base disturbances due to anuric renal failure and ongoing fluid management.

Recommendations:

1. Continue broad-spectrum antibiotics and vasopressor support to manage septic shock.
2. Monitor for signs of skin sloughing and maceration, and consider changing wound care to prevent further complications.
3. Monitor platelet count and consider adjusting antibiotic regimen or switching to alternative antibiotics to manage thrombocytopenia.
4. Continue to manage liver function tests and consider further investigation of elevated LFTs, such as MRCP or transjugular liver biopsy.
5. Continue to monitor and manage atrial fibrillation, and consider further adjustments to digoxin dose to achieve optimal rate control.
6. Consider further investigation of anuric renal failure, including CVVH and HD, and consider renal dosing of medications.
7. Monitor for signs of VAP and DVT, and consider prophylactic measures, such as elevating the head of bed and using anticoagulation therapy.
8. Continue to monitor and manage electrolyte imbalances and acid-base disturbances, and consider further investigation of anuric renal failure."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with intrahepatic cholestasis and sepsis from urinary and/or lung sources, who has been experiencing septic shock requiring vasopressin support. The patient has been treated with broad-spectrum antibiotics, including meropenem and vancomycin, and has been managed with mechanical ventilation and vasopressor support. The patient's condition is complicated by acute renal failure, thrombocytopenia, and elevated liver function tests. The patient's family has decided to withdraw care and has requested no escalation of care.

Potential Medical Complications:

1. Continued septic shock: The patient's septic shock state requires ongoing vasopressor support to maintain a mean arterial pressure (MAP) above 65 mmHg. If the patient's blood pressure drops below this threshold, it may lead to further organ dysfunction and increased mortality.
2. Acute renal failure: The patient's anuric renal failure is likely due to poor perfusion and may worsen if not managed promptly. Continued vasopressor support and consideration of renal replacement therapy (RRT) may be necessary to prevent further renal damage.
3. Thrombocytopenia: The patient's platelet count has stabilized, but may continue to drop if not managed effectively. Further monitoring and consideration of platelet transfusions may be necessary to prevent bleeding complications.
4. Elevated liver function tests: The patient's liver function tests (LFTs) are elevated, which may indicate ongoing intrahepatic cholestasis or obstructive liver disease. Further evaluation with imaging studies (e.g., MRCP) may be necessary to determine the cause of the elevated LFTs.
5. Skin complications: The patient's diffuse anasarca and weeping skin increase the risk of skin sloughing and infection. Wound care and consideration of skin substitutes may be necessary to prevent further complications.
6. Diastolic heart failure: The patient's hemodynamic instability and renal failure may worsen if not managed promptly. Continued monitoring and consideration of diuretics and vasopressors may be necessary to improve cardiac function.
7. Electrolyte imbalance: The patient's anuric renal failure and ongoing diuretic therapy may lead to electrolyte imbalances, which may worsen if not managed promptly. Regular electrolyte monitoring and supplementation may be necessary to prevent complications.

Overall, the patient's condition is complex and requires close monitoring and management to prevent further complications and improve outcomes."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with a history of atrial fibrillation, diastolic heart failure, and intrahepatic cholestasis. He was admitted with grossly abnormal liver function tests (LFTs) due to sepsis from a urinary tract infection (UTI) and MRSA pneumonia. He developed anuric renal failure and is currently on vasopressin support for septic shock. The patient has a history of antibiotics, including vancomycin and meropenem, and has been treated for MRSA pneumonia and E. coli UTI.

The patient's vital signs are stable, with a temperature of 36.8C, heart rate of 99 bpm, and blood pressure of 116/60 mmHg. He is receiving oxygen therapy and mechanical ventilation. His respiratory support includes continuous positive airway pressure (CPAP) and pressure support ventilation (PSV) with a fraction of inspired oxygen (FiO2) of 50%.

The patient's laboratory results show elevated levels of liver enzymes, including aspartate aminotransferase (AST) and alanine aminotransferase (ALT), as well as elevated levels of bilirubin and alkaline phosphatase. His complete blood count (CBC) shows thrombocytopenia, with a platelet count of 73 x 10^9/L. His electrolyte levels are abnormal, with hypokalemia and hypocalcemia.

The patient's imaging studies, including a chest X-ray (CXR), show bilateral large effusions and underlying MRSA pneumonia. His microbiology results show E. coli and Enterococcus in his urine, and MRSA in his bronchoalveolar lavage (BAL) fluid.

Potential medical complications:

1. Continued septic shock: The patient's septic shock is likely to persist, and he may require continued vasopressor support to maintain his blood pressure.
2. Acute kidney injury: The patient's anuric renal failure is likely to continue, and he may require dialysis to manage his electrolyte imbalances and fluid overload.
3. Liver failure: The patient's intrahepatic cholestasis may progress to liver failure, which could lead to coagulopathy, encephalopathy, and death.
4. Respiratory failure: The patient's MRSA pneumonia may worsen, leading to respiratory failure and the need for mechanical ventilation.
5. Thrombocytopenia: The patient's thrombocytopenia may worsen, increasing his risk of bleeding and hemorrhage.
6. Electrolyte imbalance: The patient's electrolyte imbalance may worsen, leading to cardiac arrhythmias, muscle weakness, and other complications.
7. Skin breakdown: The patient's diffuse anasarca and weeping skin may lead to skin breakdown and the risk of skin sloughing.

Given the patient's complex medical condition and potential complications, it is essential to continue close monitoring and management to prevent further deterioration and optimize his care."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
   ------ Protected Section ------
   Critical Care
   After family discussion made CMO and extubated. We are maintaining
   comfort with iv morphine. No evidence of breathlessness or pain.
   Time spent 35 min
   Critically ill
   ------ Protected Section Addendum Entered By:[**Initials (NamePattern4) **] [**Last Name (NamePattern4) 56**] [**Last Name (NamePattern1) 37**], MD
   on:[**2181-10-24**] 19:06 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
   ------ Protected Section ------
   Critical Care
   After family discussion made CMO and extubated. We are maintaining
   comfort with iv morphine. No evidence of breathlessness or pain.
   Time spent 35 min
   Critically ill
   ------ Protected Section Addendum Entered By:[**Initials (NamePattern4) **] [**Last Name (NamePattern4) 56**] [**Last Name (NamePattern1) 37**], MD
   on:[**2181-10-24**] 19:06 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with a history of atrial fibrillation, diastolic heart failure, and recent admission for sepsis caused by a urinary tract infection (UTI) and MRSA pneumonia. He is currently in anuric renal failure and has developed intrahepatic cholestasis. He is receiving broad-spectrum antibiotics, vasopressin, and other medications to manage his condition. His vital signs are stable, but his respiratory and cardiac status are concerning. He has a DNR/DNI code status and the family has decided to withdraw care and transition to comfort measures.

Potential Medical Complications:

1. Sepsis-related organ dysfunction: The patient's sepsis is causing multi-organ dysfunction, including renal failure, intrahepatic cholestasis, and respiratory failure.
2. Respiratory failure: The patient's respiratory status is concerning, with bilateral large effusions and underlying MRSA pneumonia.
3. Anuric renal failure: The patient's renal function is severely compromised, and he is at risk for further deterioration.
4. Intrahepatic cholestasis: The patient's liver function is abnormal, and he is at risk for further liver damage.
5. Thrombocytopenia: The patient's platelet count is low, and he is at risk for bleeding complications.
6. Shock: The patient is in septic shock and requires vasopressin support to maintain his blood pressure.
7. Skin breakdown: The patient has diffuse anasarca and weeping skin, which increases his risk of skin sloughing and infection.
8. Malnutrition: The patient is at risk for malnutrition due to his inability to eat and his decreased caloric intake.
9. Infection: The patient has a high risk of developing further infections due to his compromised immune system and presence of central lines and other invasive devices.
10. Code status: The patient's DNR/DNI code status may lead to a withdrawal of care and comfort measures, which may not be in line with his wishes or values."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications can be identified:

Summary:

The patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia. He is currently in an anuric renal failure and has been diagnosed with septic shock, hypoxic respiratory failure, acute renal failure, thrombocytopenia, and elevated LFTs. The patient's condition is complex, and his family has requested no escalation of care today, with a likely plan for comfort measures only (CMO) and withdrawal of care today.

Potential Medical Complications:

1. Continued septic shock: The patient's septic shock physiology requires ongoing vasopressor support, and there is a risk of continued organ dysfunction and mortality.
2. Worsening anuric renal failure: The patient's anuric renal failure may worsen, leading to further electrolyte imbalances and potential complications such as acidosis, hyperkalemia, and uremic encephalopathy.
3. Respiratory failure: The patient's hypoxic respiratory failure may worsen, leading to further respiratory distress, hypoxia, and potentially life-threatening complications.
4. Thrombocytopenia: The patient's thrombocytopenia may worsen, leading to increased bleeding risk and potential complications such as intracranial hemorrhage.
5. Elevated LFTs: The patient's elevated LFTs may indicate ongoing liver dysfunction, which could lead to further complications such as coagulopathy, encephalopathy, and potentially life-threatening liver failure.
6. Skin complications: The patient's diffuse anasarca and weeping skin may lead to skin sloughing, infection, and potential complications such as sepsis and organ failure.
7. Malnutrition: The patient's anuric renal failure and limited oral intake may lead to malnutrition, which could exacerbate his underlying conditions and increase his risk of complications.
8. Electrolyte imbalances: The patient's anuric renal failure may lead to electrolyte imbalances, which could exacerbate his underlying conditions and increase his risk of complications.
9. Cardiovascular complications: The patient's atrial fibrillation and underlying heart disease may lead to further cardiovascular complications, such as heart failure, cardiogenic shock, and potentially life-threatening arrhythmias.

In summary, the patient's condition is complex and critical, and he requires ongoing intensive care and management to address his multiple medical complications."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   Microbiology
   - no new microbiology
   -
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   Microbiology
   - no new microbiology
   -
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old individual with a history of atrial fibrillation, diastolic heart failure, and sepsis from a urinary tract infection (UTI) and MRSA pneumonia. The patient is currently in an anuric renal failure and has been diagnosed with intrahepatic cholestasis.

The patient's vital signs are as follows:

* Temperature: 36.8C (98.2F)
* Heart rate: 99 beats per minute (bpm)
* Blood pressure: 116/60 mmHg
* Respiratory rate: 22 breaths per minute (bpm)
* SpO2: 97%

The patient's laboratory results show:

* White blood cell count: 18.7
* Hematocrit: 29.8%
* Platelet count: 73
* Creatinine: 4.5 mg/dL
* Blood urea nitrogen (BUN): 102 mg/dL
* Glucose: 148 mg/dL
* Lactic acid: 1.1 mmol/L
* Albumin: 2.3 g/dL
* LDH: 331 IU/L
* Calcium: 8.2 mg/dL
* Magnesium: 2.6 mg/dL
* Phosphorus: 5.2 mg/dL

The patient's imaging studies show:

* No new imaging studies

The patient's microbiology results show:

* No new microbiology results

The patient's assessment and plan include:

* Continued septic shock state requiring vasopressin support
* Continued broad-spectrum antibiotics for MRSA pneumonia and urosepsis
* Limitation of intravenous fluids due to anuric renal failure
* Consideration of continuous renal replacement therapy (CRRT) or hemodialysis (HD)
* Continued titration of digoxin to achieve rate control
* Wound care recommendations for diffuse anasarca with weeping skin
* Holding beta blockers and lasix due to hemodynamic instability and renal failure
* Holding IV fluids and repleting electrolytes as needed
* Tube feeds and glycemic control

Potential medical complications that can arise from the patient's conditions include:

* Further deterioration of renal function
* Development of acute tubular necrosis (ATN)
* Progression of intrahepatic cholestasis to liver failure
* Development of bleeding complications due to thrombocytopenia
* Development of respiratory failure due to MRSA pneumonia
* Development of cardiac arrhythmias due to atrial fibrillation
* Development of skin sloughing due to anasarca and weeping skin
* Development of electrolyte imbalances due to anuric renal failure and IV fluid limitation

It is essential to closely monitor the patient's condition and adjust treatment accordingly to prevent or manage these potential complications."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, admitted with grossly abnormal liver function tests (LFTs) and sepsis from a urinary tract infection (UTI) and MRSA pneumonia. He is currently in anuric renal failure, requiring vasopressin support for septic shock. His condition has deteriorated, and the family has requested no escalation of care, with a likely plan for withdrawal of care today.

Potential medical complications:

1. Worsening septic shock: The patient's septic shock physiology requires pressors, and his condition is likely to deteriorate further without effective treatment.
2. Acute kidney injury: The patient's anuric renal failure is likely to progress, leading to worsening electrolyte imbalances and acidosis.
3. Liver dysfunction: The patient's intrahepatic cholestasis may worsen, leading to further liver damage and potential liver failure.
4. Respiratory failure: The patient's MRSA pneumonia may worsen, leading to further respiratory failure and potential need for mechanical ventilation.
5. Thrombocytopenia: The patient's platelet count is likely to continue to drop, increasing the risk of bleeding complications.
6. Skin complications: The patient's diffuse anasarca and weeping skin increase the risk of skin sloughing and potential infections.
7. Electrolyte imbalance: The patient's anuric renal failure and ongoing electrolyte losses may lead to significant electrolyte imbalances, including hyperkalemia, hypocalcemia, and acidosis.

Recommendations:

1. Continue broad-spectrum antibiotics to cover E. coli, Enterococcus, and MRSA.
2. Maintain vasopressin support to manage septic shock.
3. Consider CVVH and HD to manage anuric renal failure.
4. Monitor platelet count and consider adjusting antibiotic therapy or switching to a different antibiotic to minimize thrombocytopenia.
5. Continue to moisturize skin to prevent maceration and consider air mattress to reduce risk of skin sloughing.
6. Replete electrolytes as needed to manage electrolyte imbalances.
7. Consider MRCP to evaluate for CBD obstruction in setting of elevated AP and TB.
8. Continue to titrate digoxin dose to effect to manage atrial fibrillation.
9. Consider withdrawing care in accordance with the patient's and family's wishes."
